Search

Search Results
Results 5441 - 5450 of 9450 for emergency medicine
  • Drug - 16 Jan 2025
    Consumer Medicine Information (CMI) about Neotigason intended for persons living in Australia.
  • Drug - 15 Jan 2025
    Consumer Medicine Information (CMI) about Minims Atropine Sulphate intended for persons living in Australia.
  • Drug - 13 Jan 2025
    Consumer Medicine Information (CMI) about Staquis intended for persons living in Australia.
  • Drug - 10 Jan 2025
    Consumer Medicine Information (CMI) about Saxenda intended for persons living in Australia.
  • News - 7 Jan 2025
    The study highlights T2-low and T17-high asthma endotypes in minoritized youths, offering insights for precision medicine and improved asthma management.
  • Drug - 7 Jan 2025
    Consumer Medicine Information (CMI) about Minims Oxybuprocaine Hydrochloride intended for persons living in Australia.
  • Drug - 6 Jan 2025
    Consumer Medicine Information (CMI) about Alecensa intended for persons living in Australia.
  • News - 3 Jan 2025
    Kosali Simon, PhD, M.A., a professor with the Paul H. O'Neill School of Public and Environmental Affairs and a Regenstrief Institute research scientist; and Katherine Baicker, PhD, University of...
  • Drug - 20 Dec 2024
    Consumer Medicine Information (CMI) about Vocabria intended for persons living in Australia.
  • Drug - 20 Dec 2024
    Consumer Medicine Information (CMI) about Apretude Tablets intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.